Literature DB >> 26062997

Evaluating the Role of HLA-DM in MHC Class II-Peptide Association Reactions.

Liusong Yin1, Zachary J Maben1, Aniuska Becerra1, Lawrence J Stern2.   

Abstract

Ag presentation by MHC class II (MHC II) molecules to CD4(+) T cells plays a key role in the regulation of the adaptive immune response. Loading of antigenic peptides onto MHC II is catalyzed by HLA-DM (DM), a nonclassical MHC II molecule. The mechanism of DM-facilitated peptide loading is an outstanding problem in the field of Ag presentation. In this study, we systemically explored possible kinetic mechanisms for DM-catalyzed peptide association by measuring real-time peptide association kinetics using fluorescence polarization assays and comparing the experimental data with numerically modeled peptide association reactions. We found that DM does not facilitate peptide association by stabilizing peptide-free MHC II against aggregation. Moreover, DM does not promote transition of an inactive peptide-averse conformation of MHC II to an active peptide-receptive conformation. Instead, DM forms an intermediate with MHC II that binds peptide with faster kinetics than MHC II in the absence of DM. In the absence of peptides, interaction of MHC II with DM leads to inactivation and formation of a peptide-averse form. This study provides novel insights into how DM efficiently catalyzes peptide loading during Ag presentation.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26062997      PMCID: PMC4490944          DOI: 10.4049/jimmunol.1403190

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  78 in total

1.  Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association.

Authors:  Gijsbert M Grotenbreg; Melissa J Nicholson; Kevin D Fowler; Kathrin Wilbuer; Leah Octavio; Maxine Yang; Arup K Chakraborty; Hidde L Ploegh; Kai W Wucherpfennig
Journal:  J Biol Chem       Date:  2007-05-24       Impact factor: 5.157

2.  Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond.

Authors:  Andrea Ferrante; Jack Gorski
Journal:  J Immunol       Date:  2009-12-28       Impact factor: 5.422

Review 3.  Fitting enzyme kinetic data with KinTek Global Kinetic Explorer.

Authors:  Kenneth A Johnson
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

4.  Mediation by HLA-DM of dissociation of peptides from HLA-DR.

Authors:  V S Sloan; P Cameron; G Porter; M Gammon; M Amaya; E Mellins; D M Zaller
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

5.  HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.

Authors:  C L Chou; S Sadegh-Nasseri
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

6.  Editing of the HLA-DR-peptide repertoire by HLA-DM.

Authors:  H Kropshofer; A B Vogt; G Moldenhauer; J Hammer; J S Blum; G J Hämmerling
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

7.  HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide.

Authors:  Anne-Kathrin Anders; Melissa J Call; Monika-Sarah E D Schulze; Kevin D Fowler; David A Schubert; Nilufer P Seth; Eric J Sundberg; Kai W Wucherpfennig
Journal:  Nat Immunol       Date:  2010-12-05       Impact factor: 25.606

8.  HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules.

Authors:  L K Denzin; C Hammond; P Cresswell
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

9.  HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.

Authors:  Abigail I Guce; Sarah E Mortimer; Taejin Yoon; Corrie A Painter; Wei Jiang; Elizabeth D Mellins; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2012-12-09       Impact factor: 15.369

Review 10.  HLA-DM Focuses on Conformational Flexibility Around P1 Pocket to Catalyze Peptide Exchange.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  Front Immunol       Date:  2013-10-17       Impact factor: 7.561

View more
  12 in total

1.  Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide-MHC complexes.

Authors:  Lance M Hellman; Liusong Yin; Yuan Wang; Sydney J Blevins; Timothy P Riley; Orrin S Belden; Timothy T Spear; Michael I Nishimura; Lawrence J Stern; Brian M Baker
Journal:  J Immunol Methods       Date:  2016-02-18       Impact factor: 2.303

2.  Loading Rate of Exogenous and Autoantigenic Determinants on Major Histocompatibility Complex Class II Mediates Resistance to Multiple Sclerosis.

Authors:  A E Mamedov; M Yu Zakharova; O O Favorova; O G Kulakova; A N Boyko; V D Knorre; N A Vorobieva; E N Khurs; I S Kiselev; N M Baulina; A G Gabibov; A A Belogurov
Journal:  Dokl Biochem Biophys       Date:  2019-06-14       Impact factor: 0.788

Review 3.  The melting pot of the MHC II peptidome.

Authors:  Lawrence J Stern; Laura Santambrogio
Journal:  Curr Opin Immunol       Date:  2016-03-25       Impact factor: 7.486

Review 4.  Exogenous antigens bind MHC class II first, and are processed by cathepsins later.

Authors:  Scheherazade Sadegh-Nasseri; AeRyon Kim
Journal:  Mol Immunol       Date:  2015-08-05       Impact factor: 4.407

5.  Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases.

Authors:  Guo Luo; Ling Lin; Louis Jacob; Mélodie Bonvalet; Aditya Ambati; Giuseppe Plazzi; Fabio Pizza; Ryan Leib; Christopher M Adams; Markku Partinen; Emmanuel Jean-Marie Mignot
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

Review 6.  The Other Function: Class II-Restricted Antigen Presentation by B Cells.

Authors:  Lital N Adler; Wei Jiang; Kartik Bhamidipati; Matthew Millican; Claudia Macaubas; Shu-Chen Hung; Elizabeth D Mellins
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

Review 7.  Predicting Antigen Presentation-What Could We Learn From a Million Peptides?

Authors:  David Gfeller; Michal Bassani-Sternberg
Journal:  Front Immunol       Date:  2018-07-25       Impact factor: 7.561

8.  HLA class II sequence variants influence tuberculosis risk in populations of European ancestry.

Authors:  Gardar Sveinbjornsson; Daniel F Gudbjartsson; Bjarni V Halldorsson; Karl G Kristinsson; Magnus Gottfredsson; Jeffrey C Barrett; Larus J Gudmundsson; Kai Blondal; Arnaldur Gylfason; Sigurjon Axel Gudjonsson; Hafdis T Helgadottir; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Ari Karason; Ljiljana Bulat Kardum; Jelena Knežević; Helgi Kristjansson; Mar Kristjansson; Arthur Love; Yang Luo; Olafur T Magnusson; Patrick Sulem; Augustine Kong; Gisli Masson; Unnur Thorsteinsdottir; Zlatko Dembic; Sergey Nejentsev; Thorsteinn Blondal; Ingileif Jonsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2016-02-01       Impact factor: 38.330

9.  Deciphering the Potential Pharmaceutical Mechanism of Chinese Traditional Medicine (Gui-Zhi-Shao-Yao-Zhi-Mu) on Rheumatoid Arthritis.

Authors:  Lin Huang; Qi Lv; Duoli Xie; Tieliu Shi; Chengping Wen
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

10.  Protective Allele for Multiple Sclerosis HLA-DRB1*01:01 Provides Kinetic Discrimination of Myelin and Exogenous Antigenic Peptides.

Authors:  Azad Mamedov; Nadezhda Vorobyeva; Ioanna Filimonova; Maria Zakharova; Ivan Kiselev; Vitalina Bashinskaya; Natalia Baulina; Alexey Boyko; Alexander Favorov; Olga Kulakova; Rustam Ziganshin; Ivan Smirnov; Alina Poroshina; Igor Shilovskiy; Musa Khaitov; Yuri Sykulev; Olga Favorova; Valentin Vlassov; Alexander Gabibov; Alexey Belogurov
Journal:  Front Immunol       Date:  2020-01-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.